229 event(s) found
Cancer Research into Action
To close its wonderful 60th anniversary year, IARC will offer you the opportunity to register for a major scientific conference that will take place over three days, from 19 to 21 May 2026. This conference will bring together experts from around the world and will be held at IARC and la Halle Tony Garnier.
6th SUNRiSE Meeting
6th SUNRiSE Meeting organized by SUNRiSE Network
54 reunión anual PETHEMA
Latest edition of PETHEMA's annual meeting, held in Spanish. More information coming soon…
ASCO® Annual Meeting 2026
The ASCO Annual Meeting is more than a conference—it’s the place to be a part of something bigger. This is where groundbreaking science, innovation, and connection come together to shape the future of cancer care.
Clinical Ethics: End-of-Life Care
Clinical Ethics: End-of-Life Care organized by Deakin Bioethics (Deakin University)
SIFEM 2026 - Osons repenser les dogmes
In French: "Ce congrès sera l’occasion de revisiter les dogmes en imagerie du sein et du pelvis, de confronter les idées reçues aux données les plus récentes, et de proposer des alternatives éclairées aux paradigmes établis." Nous aborderons des sujets très pratiques, partagerons nos difficultés et discuterons ensemble des pièges rencontrés au quotidien dans notre pratique de l’imagerie de la femme, qu’il s’agisse de la pertinence des examens, de l’intégration de l’intelligence artificielle ou d’une meilleure anticipation des défis cliniques, technologiques et organisationnels auxquels nous faisons face chaque jour."
EACR 2026 Congress
The 2026 Annual Congress of the European Association for Cancer Research (EACR 2026) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
Symposium iTOX 2026
In French: "Le symposium ITOX 2026 réunit des experts nationaux et internationaux pour aborder les toxicités liées aux immunothérapies en cancérologie, avec un focus particulier sur les effets indésirables des inhibiteurs de points de contrôle immunitaires et des thérapies cellulaires (CAR-T, T-cell engagers). Le programme comprend : - Sessions éducatives en français : "Nouvelles" immunothérapies antitumorales Toxiciés des ADC / immunoconjugués cytotoxiques Evolution des prises en charges Pièges diagnostiques - Discussion de cas cliniques complexes Points de vue des patient.es sur les effets indésirables immuno-médiés - Sessions orales en anglais : Cellular therapies Keynote lecture Dissecting the mechanism of … Immunosuppressive drugs Cet événement est un lieu privilégié d’échanges interdisciplinaires entre oncologues, immunologistes, internistes, chercheurs et cliniciens impliqués dans la prise en charge des patients traités par immunothérapies."
EHA2026 Congress
EHA2026 will once again offer an exceptional scientific program, featuring a seamless flow of engagement across Plenary Sessions—including the Opening Ceremony, Plenary Abstracts Session, and Presidential Sessions—alongside carefully curated Sponsor Symposiums spread throughout each Congress day.
SFCO : Congrès 2026
In French: "Face aux mutations rapides de notre environnement – innovations technologiques, évolutions thérapeutiques, attentes accrues en termes de qualité et de personnalisation des soins – la chirurgie oncologique se trouve à un tournant. Ce congrès se veut le lieu de la réflexion collective, de l’audace scientifique et du partage d’expertise. Durant ces deux journées, nous aurons l’occasion d’explorer les enjeux majeurs à venir : progrès technologiques, prise en charge multidisciplinaire, adaptation des pratiques aux nouvelles réalités, et maintien de l’excellence chirurgicale pour servir au mieux nos patients."
6ème Journée de l’innovation en cancérologie pulmonaire
In French: "La journée consacrée aux Innovations dans le traitement du Cancer Pulmonaire est de retour."
EORTC-ESMO-AACR Methods in Clinical Cancer Research Workshop
The annual Methods in Clinical Cancer Research Workshop (MCCR) is a week-long course designed to educate and train early-career investigators in the best practices of clinical trial design and provide access to experienced clinical investigators from different institutions and countries with expertise across all areas of clinical research.
Drug Discovery Europe - Part of Discovery & Development Europe 2026
Join world-leading experts at our annual Drug Discovery, Neuroscience Drug Development, and Automation & AI & Data programmes—showcasing bold strategies, breakthrough science, and cutting-edge technologies in target discovery, medicinal chemistry, and drug design. Gain fresh insights from case studies on PROTACs, ADCs, molecular glues, and the power of AI-driven tools in early R&D. Discover advances in tackling neuroscience and age-related diseases, strategies to cross the blood–brain barrier, and the data-driven digital tech transforming discovery workflows.
Target Innovation & Novel Screening Technologies
We’re partnering with Oxford Global to host an ELRIG scientific track as part of their Drug Discovery Europe 2026 conference.
Drug Discovery USA 2026: Emerging multifunctional small molecule and biologic approaches to drug difficult targets
Recent advances in chemical biology and protein engineering are expanding the boundaries of which proteins can be modulated pharmacologically. Multifunctional small molecules (such as molecular glues, targeted protein degraders, and allosteric modulators) are enabling precise control over protein stability, localization and activity, often by exploiting endogenous cellular pathways. In parallel, novel biologic modalities, including engineered antibodies, multi-specific binders, peptide scaffolds, nucleotide and RNA therapeutics, offer complementary strategies to engage complex or transient target surfaces with high affinity and specificity. Collectively, these approaches are reshaping early‑stage drug discovery by providing versatile platforms to modulate challenging targets through mechanisms beyond simple inhibition. Furthermore, hybrid strategies that integrate small molecules with biologics, such as antibody–drug conjugates (ADCs) and chemically enhanced biologics, are demonstrating synergistic potential. Together, these emerging technologies highlight a rapidly evolving therapeutic landscape in which difficult to drug targets are increasingly accessible, opening new avenues for disease intervention and precision medicine. Continued innovation in molecular design, delivery, and mechanistic understanding will be critical to fully realize the promise of these next‑generation modalities.
21ème Journées GSF-GETO
21ème Journées GSF-GETO organized by GSF
Cell Symposia: Multifaceted mitochondria
Cell Symposia: Multifaceted mitochondria organized by Cell (Elsevier Ltd.)
MASCC/ISOO 2026 Annual Meeting
The MASCC/ISOO Annual Meeting is the leading international, interdisciplinary event dedicated to supportive cancer care. Our 2026 theme—Coordinated and Individualized Supportive Cancer Care—reflects our commitment to advancing care that is both evidence-based and patient-centered. Jo Bowen This year’s program will spotlight three key areas: “Mind the Gap”: Maximizing Access to Supportive Care for All Addressing disparities in supportive care for underserved communities, including those in rural and remote areas; gender and sexually diverse populations; culturally and linguistically diverse groups; older adults; individuals of lower socioeconomic status; those in low- and middle-income countries; and First Nations Peoples. Lifestyle and Behavioral Support in Cancer Care Exploring the role of exercise, nutrition, integrative medicine, psychotherapy, and digital health technologies in enhancing care during and after treatment. Optimizing Toxicity Management of Novel Therapies Focusing on the prediction, assessment, and management of toxicities associated with emerging cancer treatments. In addition to these focus areas, the program will feature a broad range of sessions led by MASCC/ISOO study groups, covering topics that address the full spectrum of challenges faced by patients during and after treatment. The meeting offers excellent opportunities for networking, collaboration, and the chance to present your own research to a global audience. Social events will showcase Melbourne’s vibrant food, arts, and sports scenes—making the meeting both enriching and memorable.
Prague Metabolism and Signaling Symposium
Prague Metabolism and Signaling Symposium organized by Prague Metabolism Symposium
Advances in Malignant Lymphoma: From Discovery to Clinical Impact
The fifth Advances in Malignant Lymphoma: From Discovery to Clinical Impact conference, held in cooperation with the International Conference on Malignant Lymphoma (ICML), will convene experts from academia, industry, government, and foundations to examine how molecular mechanisms and translational research are driving therapeutic progress. The program will highlight advances in understanding germinal center biology and beyond, lymphoma origins and classifications, including rare and aggressive subtypes, and microenvironmental influences, that define disease behavior and therapeutic response. This conference is uniquely positioned to integrate scientific discoveries across epigenetics, disease modeling, and computational biology with emerging therapeutic advances in antibody evolution, next-generation clinical assessment, degraders, and cellular therapies. Together, these efforts will capture the entire spectrum of lymphoma research and drive progress toward improved patient outcomes.
ASCO Breakthrough 2026
ASCO Breakthrough 2026 organized by ASCO
ANZUP ASM 2026
ANZUP ASM 2026 organized by ANZUP
Ninth JCA-AACR Special Joint Conference on Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers
The Japanese Cancer Association (JCA) and the AACR are proud to jointly present this Ninth JCA-AACR Special Joint Conference. This international collaboration will convene leading basic scientists and clinical researchers from around the world to share cutting-edge discoveries and emerging diagnostic and therapeutic opportunities in upper digestive and head and neck cancers. The conference will foster dynamic scientific exchange and collaboration, offering ample opportunities for meaningful discussions and interactions that are essential to advancing both basic research and clinical progress in the field. Sessions will also offer slots for proffered talks selected from highly rated abstract submissions.
ESMO Gastrointestinal Cancers Congress 2026
The ESMO Gastrointestinal Cancers Congress 2026 will take place from 1 to 4 July in Munich, Germany, as well as online, through a dedicated virtual platform. This key meeting will gather world-renowned specialists, clinical researchers, and medical professionals who are at the forefront of progress in the prevention, diagnosis, and treatment of gastrointestinal cancers. With an engaging scientific agenda that includes expert-led discussions, multidisciplinary tumour boards, debates on clinical controversies, and cutting-edge research presentations, participants will gain valuable insights into the evolving landscape of GI oncology. Topics will span the full continuum of care, from early detection and biomarker-driven therapies to innovations in systemic treatment and patient quality of life. Designed to foster knowledge exchange and collaboration, the congress offers numerous opportunities to connect with peers, discuss real-world challenges, and share perspectives on advancing GI cancer care. Be part of this influential gathering to drive change, shape clinical practice, and help improve outcomes for patients worldwide.